乳腺罩定位用于不适合屏气技术的左侧乳腺癌心脏保护放疗
本研究纳入16例无法完成屏气(BH)的左侧乳腺癌(LSBC)连续患者,在2014至2016年接受辅助乳腺放疗(ABRT)时使用定制乳腺罩定位。每例患者配对比较使用与不使用乳腺罩的计划,结果显示靶区覆盖无显著差异,而心脏、左心室及同侧肺的受量均显著降低(P < .001)。
要点
- 乳腺罩定位不降低靶区覆盖,同时显著改善心脏、左心室和同侧肺的保护。
- 使用乳腺罩后心脏平均剂量由5.15 Gy降至2.15 Gy,降低58.2%。
- 左心室平均剂量由9.00 Gy降至3.27 Gy,降低63.7%;同侧肺由7.95 Gy降至5.16 Gy,降低35%。
核心结论
- 对不适合屏气技术的左侧乳腺癌患者,定位乳腺罩在辅助乳腺放疗中显著改善心脏保护,且不损害靶区覆盖。
研究设计与样本
- 研究纳入2014至2016年16例屏气失败并接受辅助乳腺放疗的左侧乳腺癌连续患者。
- 采用配对t检验比较每例患者使用与不使用乳腺罩的计划,以量化危及器官保护和靶区覆盖。
- 治疗计划采用野中野切线技术,处方剂量为42.5 Gy分16次。
主要发现
- 靶区乳腺覆盖差异无统计学意义。
- 心脏、左心室和同侧肺的保护均观察到统计学显著改善(P值 < .001)。
- 使用乳腺罩计划的心脏平均剂量为2.15 Gy,不使用为5.15 Gy,降低58.2%。
- 左心室平均剂量为3.27 Gy对9.00 Gy,降低63.7%;同侧肺为5.16 Gy对7.95 Gy,降低35%。
- 心脏受照体积为13.3 cc对59.5 cc(降低77.6%),左心室为6.2 cc对33.2 cc(降低81.2%),同侧肺为92.8 cc对162.5 cc(降低42.9%)。
关键数值与推荐
- 推荐对不适合屏气技术的左侧乳腺癌患者使用定制乳腺罩定位以降低心脏剂量。
- 使用乳腺罩后心脏平均剂量由5.15 Gy降至2.15 Gy,左心室由9.00 Gy降至3.27 Gy,同侧肺由7.95 Gy降至5.16 Gy。
- 心脏受照体积由59.5 cc降至13.3 cc,左心室由33.2 cc降至6.2 cc,同侧肺由162.5 cc降至92.8 cc。
临床怎么用
- 对无法屏气的左侧乳腺癌辅助放疗患者,可采用定制乳腺罩定位作为心脏保护策略。
- 无屏气设备的中心可将乳腺罩作为简单的心脏保护替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with left-sided breast cancer (LSBC) are at increased risk of cardiac morbidity from adjuvant breast radiation therapy (ABRT). Breath-hold (BH) techniques substantially reduce the radiation received by heart during radiation therapy for LSBC. However, a subset of patients with LSBC are ineligible for BH techniques due to an inability to breath-hold or because of other comorbidities. To reduce radiation to the heart, we routinely use a custom-made breast shell for the treatment of patients with LSBC who are ineligible for BH techniques. This study evaluates the dosimetric impact of using a breast shell for patients with LSBC undergoing ABRT. METHODS AND MATERIALS: Sixteen consecutive patients with LSBC who failed BH and underwent ABRT using a breast shell during the period of 2014 to 2016 were identified. Treatment was planned using field-in-field tangents with a prescribed dose of 42.5 Gy in 16 fractions. Comparisons between plans with and without a shell were made for each patient using a paired t test to quantify the sparing of organs at risk (OARs) and target coverage. RESULTS: There was no statistically significant difference in the planning target volume of breast coverage. A statistically significant improvement was observed in sparing the heart, left ventricle (LV), and ipsilateral lung (P-value < .001). Plans with the shell spared OARs better than the no-shell plans with a mean dose of 2.15 Gy versus 5.15 Gy (58.2% reduction) to the heart, 3.27 Gy versus 9.00 Gy (63.7% reduction) to the LV, and 5.16 Gy versus 7.95 Gy (35% reduction) to the ipsilateral lung. The irradiated volumes of OARs for plans with and without shell are 13.3 cc versus 59.5 cc (77.6% reduction) for the heart, 6.2 cc versus 33.2 cc (81.2% reduction) for the LV, and 92.8 cc versus 162.5 cc (42.9% reduction) for the ipsilateral lung. CONCLUSIONS: A positioning breast shell offers significant benefit in terms of sparing the heart for patients with LSBC who are ineligible for BH techniques. It also can be used as a simple cardiac-sparing alternative in centers without BH capability.
引用
- Joseph K, Warkentin H, Ghosh S, et al. Cardiac-sparing radiation therapy using positioning breast shell for patients with left-sided breast cancer who are ineligible for breath-hold techniques. Adv Radiat Oncol. 2017. PMID: 29204519. doi:10.1016/j.adro.2017.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。